Previous Article | Next Article ![]()
Journal of Clinical Microbiology, September 2003, p. 4016-4021, Vol. 41, No. 9
0095-1137/03/$08.00+0 DOI: 10.1128/JCM.41.9.4016-4021.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Department of Medical Microbiology, Center of Infectious Diseases, Leiden University Medical Center, Leiden,1 BioMerieux, Boxtel, The Netherlands,2 Department of Microbiology, University of Antwerp, Antwerp, Belgium3
Received 3 March 2003/ Returned for modification 14 April 2003/ Accepted 27 May 2003
|
|
|---|
|
|
|---|
Culture on buffered charcoal yeast extract (BCYE) plates is considered the gold standard for the laboratory diagnosis of Legionella infections. However, legionellae are slow-growing and fastidious bacteria, and successful culture requires selective medium and prolonged incubation periods. In addition, culture is less optimal for the non-L. pneumophila legionellae, as these often require additional supplements. Many laboratories use urine antigen detection tests, which are much more rapid for routine diagnostics, but these assays only detect a limited number of serogroups of L. pneumophila, especially the Binax Now, which detects non-L. pneumophila serogroup 1 (6). These rapid urine antigen tests have sensitivities between 60% and 85% (5, 6, 11, 14). Serological diagnosis is also commonly used, and a sensitivity of 80% has been reported (8). However, a diagnosis by a fourfold immunoglobulin G (IgG) titer increase can only be made retrospectively, and in 25% of patients no IgG titer increase is observed (8). An IgM assay can make a rapid diagnosis, but the drawback is that IgM may persist for 2 years or more (13).
Therefore, nucleic acid amplification techniques are attractive tools for detection of legionellae in clinical samples, as they are able to detect all legionellae and provide rapid results. It is, however, still important to be able to distinguish between L. pneumophila and non-L. pneumophila species, as currently more severe morbidity and mortality has been observed with L. pneumophila. Therefore, clinically the identification of the actual Legionella species is required. Diagnostic PCR assays have principally targeted specific regions within 16S rRNA genes (rDNA) (3, 9, 12, 21, 23, 26), 5S rDNA (9), or the macrophage inhibitor potentiator (mip) gene (1, 9, 15, 16, 17, 20, 22, 26). Real-time PCR has added benefits to routine diagnosis, as it minimizes manual time for the PCR and negates the use of post-PCR analysis. A few real-time protocols have been reported with the Lightcycler (1, 9, 21, 23, 26) but the dual target assays require melt-curve analysis to distinguish L. pneumophila from non-L. pneumophila (21, 23).
Here we describe the development of a sensitive, specific multiplex PCR assay for the simultaneous detection and discrimination of Legionella spp. and Legionella pneumophila with an internal control in clinical specimens.
|
|
|---|
Twelve different serogroups of L. pneumophila (serogroups 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, and 14) and 24 non-L. pneumophila species were used establish the specificity and sensitivity of the PCR assays. The 24 non-L. pneumophila Legionella species were L. anisa L. birminghamensis, L. bozemanii group 1, L. brunensis, L. cherrii, L. dumoffii, L. feeleii -1, L. gormanii, L. israelensis, L. jamestowniensis, L. jordanis, L. longbeachae 1, L longbeachae 2, L. maceachernii, L. micadadei, L. moravica, L. oakridgens, L. parisensis, L. rubrilucens, L. sainthelensis, L. santicrusis L. spiritensis, L. steigerwaltii, and L. tucsonensis. The Legionella strains were grown at 37°C on buffered charcoal yeast extract (BCYE) agar for 48 to 72 h. The incubation period for the diagnostic culture was 10 days.
To evaluate the sensitivity of the PCR test, all the Legionella strains (36 in total) were suspended in sterile physiological saline at a concentration equivalent to 108 cells per ml, based on McFarland turbidimetric standards. Serial dilutions were made from the suspension and aliquots were extracted and tested in the PCR to determine sensitivity.
Clinical material. To evaluate the sensitivity of the PCR test for legionellae on clinical samples, sputum, throat swab, and bronchoalveolar lavage samples were all spiked with L. pneumophila (ATCC 33152) based on McFarland turbidimetric standards. Serial dilutions were made from the suspension and aliquots were extracted and tested in the PCR to determine sensitivity.
Retrospectively, 10 clinical samples which were known to be culture positive for Legionella species were tested. Five were obtained from the Kapellen outbreak (28), four from patients presenting with community-acquired pneumonia, and one from a patient presenting with nosocomial pneumonia. All the samples from the Kapellen outbreak were grouped as L. pneumophila serogroup 1, the other patient samples were L. pneumophila serogroup 1 (three samples) and serogroup 6 (one sample), and the nosocomial patient sample was L. bozemanii. Prospectively 64 bronchoalveolar lavage samples and 10 throat swab samples from hospitalized patients with pneumonia were also tested; all were cultured for Legionella species. A summary of the clinical samples is shown in Table 3.
|
View this table: [in a new window] |
TABLE 3. Culture and real-time PCR results for clinical samplesa
|
DNA extraction. Nucleic acids were extracted from the suspensions of all bacterial colonies and the clinical samples with the High Pure PCR Template preparation kit (Roche, Mannheim, Germany). Sputum samples were treated with sputolysin reagent prior to DNA extraction. (Calbiochem, Darmstadt, Germany). The sputum was mixed with three parts sputolysin, vortexed, and incubated for 10 min at room temperature. The mixture was centrifuged for 10 min at 1,000 x g. The sediment was resuspended in Tris-EDTA buffer and stored at -80°C prior to extraction. All other nucleic acid extraction from samples was performed without any preceding steps according to the manufacturer's instructions.
Briefly, 200 µl of the samples was lysed by adding 200 µl of binding buffer and proteinase K and incubation at 72°C for 10 min. After adding 100 µl of isopropanol, the solution was passed through a silica column by centrifugation at 6,000 x g for 1 min. The columns were washed three times and centrifuged at 6,000 x g for 1 min. Purified nucleic acids were eluted in 200 µl of elution buffer, which was warmed to 70°C and stored at -20°C. DNA of L. pneumophila serogroup 1 (ATCC 33152) was used as a positive control. The controls included in each run encompassed a no-template control after every 10 samples, a control for the extraction, and any buffers to ensure no contamination with Legionella species. In the negative control, molecular grade water was added instead of specimen.
Primers and probes for real-time PCR. Primer and molecular beacon sequences were selected from an alignment of nucleotide sequences of the 16s RNA gene of Legionella species from GenBank The aim of this assay was to select primers and probes that would detect all Legionella species but no other organisms. Primer and molecular beacon sequences were selected from the mip gene of L. pneumophila with criteria required for design of molecular beacon assays (accession no. AF095229). The aim of this assay was to amplify only L. pneumophila serogroups and no other Legionella species. The PCR primers were optimized with the primer 3 program (http://www-genome.wi.mit.edu/cgi-bin/primer/primer3_www.cgi) to ensure no secondary structures.
The molecular beacon was designed with the Mfold Zuker program (http://www.bioinfo.rpi.edu/applications/mfold/old/dna/). Criteria for a good molecular beacon included a melting temperature of 5 to 10°C over the melting temperature of the primers and limited secondary structure in the target sequence. The stem sequence was selected to have a compatible melting temperature to the molecular beacon. The beacon formed a stable structure at 50°C to 55°C, the proposed annealing temperature, with no secondary structures. For the Legionella species assay, the fluorescent reporter on the 5' end of the probe was 6-carboxy-fluorescein (FAM), and the quencher on the 3' end was Dabcyl. For the L. pneumophila assay, the fluorescent reporter on the 5' end of the molecular beacon was hexachlorofluorescein (HEX) and the quencher on the 3' end was Dabcyl. The phocine herpesvirus (PhHV) internal control probe was labeled with indodicarbocyanine (Cy-5) and Black Hole Quencher 2. Biolegio prepared the molecular beacons and primers (Biolegio, Malden, The Netherlands). Selected primers and probes are shown in Table 1.
|
View this table: [in a new window] |
TABLE 1. Primers and probes for PCR amplification of Legionella spp. (16S rRNA gene) and L. pneumophila (mip gene)
|
Multiplex PCR including internal control. The multiplex PCR was designed with a PhHV internal control as described by Templeton et al. (24). The real-time PCR for Legionella spp. was performed in a reaction mixture consisting of 25 µl of HotStary Taq master mix kit (Qiagen, Hilden, Germany) 4.5 mM MgCl2, 0.3 µM each of the four Legionella primers, 0.2 µM phocine herpesvirus primers, 0.44 µM each of the two Legionella molecular beacons, 0.24 µM phocine herpesvirus molecular beacon, and 10 µl of template. The PCR thermal profile was identical to that of the individual assays. Amplification, detection, and data analysis were performed with an iCycler IQ real-time detection system (Bio-Rad, Veenendaal, The Netherlands).
Determination of intra-assay and interassay variation. DNA was extracted from L. pneumophila serogroup 1 (ATCC 33152) and stored in AE (Tris-EDTA) buffer (Qiagen, Hilden, Germany). The DNA was diluted to a concentration equivalent to 5,000 CFU/ml and stored in small aliquots at -20°C. In order to determine inter- and intra-assay variation, an aliquot was thawed and run in quintuplicate in five consecutive runs of the multiplex real-time PCR assay.
DNA sequencing and Legionella species identification. Products of the 16S rRNA gene PCR were sequenced with a 310 Genetic Analyser (Applied Biosystems, Warrington, England) with a Big Dye terminator cycle sequencing ready reaction (Applied Biosystems, Warrington, England. For the sequencing, 0.1 µM primer was used. Identification of Legionella species was done by comparison of the gene sequence obtained with the sequences in GenBank.
|
|
|---|
Sensitivity. Sensitivity was determined by analyzing dilutions of the extracted DNA of Legionella spp. and L. pneumophila. The number of cells per milliliter was based on McFarland turbimetric standards. The dilutions obtained were cultured on BCYE to determine CFU; 200 µl of the dilutions obtained which related to the CFU were extracted and resuspended in 200 µl of buffer. The sensitivity was 2.5 CFU/ml for all the L. pneumophila serogroups. The Legionella. assay also had a sensitivity of 2.5 CFU/ml for the 24 non-L. pneumophila strains tested.
Optimization of multiplex assay. Both Legionella real-time PCR assays were first optimized as a monoassay. A 10-fold dilution series of Legionella DNA was used to make a standard curve, and this was analyzed by means of the iCycler IQ real-time detection apparatus software to determine assay efficiency and correlation coefficient. Theoretically, no loss in sensitivity is observed in a multiplex assay if two 100% efficient assays are combined. The efficiency obtained was 100%, 103%, and 97% for the Legionella spp. assay, L. pneumophila assay, and PhHV assay, respectively (Fig. 1). The multiplex assay was optimized, and thereafter, the cycle threshold (Ct) values obtained from testing a dilution series of L. pneumophila in the individual assay and the multiplex assay were similar, indicating the same level of sensitivity. (Table 2). The specificity of the multiplex assay was no different from that of the individual assay. The different fluorescent labels on the beacons had no cross-reaction in the iCycler real-time detection system, and therefore the different probes could be distinguished easily (Fig. 2).
![]() View larger version (61K): [in a new window] |
FIG. 1. (A) Relative fluorescence units obtained for a 10-fold dilution series of L. pneumophila ATCC 33152 from 107 to 102 CFU/ml for the Legionella spp. assay. Each dilution gives a Ct value which can be plotted against the CFU to obtain a standard curve. The value obtained for the slope of the line gives a value for PCR efficiency; in this case it is 100%. (B) Relative fluorescence units obtained for a 10-fold dilution series of L. pneumophila ATCC 33152 from 107 to 102 CFU/ml for the L. pneumophila assay. Each dilution gives a Ct value which can be plotted against the CFU to obtain a standard curve. The value obtained for the slope of the line gives a value for PCR efficiency; in this case it is 102.7%.
|
|
View this table: [in a new window] |
TABLE 2. Comparison of Ct values in monoassay and multiplex assay after real-time amplification of a dilution series of an L. pneumophila serogroup 1 standard
|
![]() View larger version (92K): [in a new window] |
FIG. 2. Determination of results. Each panel displays the readout from the multiplex PCR with the fluorophore indicated. (A) Sample positive for L. pneumophila, showing fluorescence with FAM (Legionella spp.), HEX (L. pneumophila), and Cy-5 (internal control). (B) Sample positive for Legionella spp. but not L. pneumophila, showing fluorescence with FAM (Legionella spp.) and Cy-5 (internal control). (C) Negative samples, showing fluorescence only with Cy-5 (internal control).
|
Evaluation of clinical material in multiplex assay. Sputum, throat swab, and bronchoalveolar lavage samples were all spiked with L. pneumophila (ATCC 33152) at 5,000 CFU/ml, 500 CFU/ml, and 50 CFU/ml, and serial dilutions of the extracted DNA were performed. The sensitivity of both assays in the multiplex was 10 CFU/ml of spiked sputum, bronchoalveolar lavage, and throat swab samples. The amount of sample spiked into the samples did not affect the final sensitivity.
The results from the clinical samples tested as part of the proficiency panel were all as expected. The 12 positive samples were detected by both assays, and the eight negative samples were negative by both assays, resulting in a 100% score. In this assay, the weakly positive samples had a mean Ct value of 27 (range, 23 to 29).
Clinical samples shown to be culture positive were analyzed retrospectively and were all detected by the multiplex PCR. Nine of the samples were shown to contain L. pneumophila and were detected by both assays. One sample was L. bozemanii, and this was only detected by the Legionella species assay. Of the clinical samples analyzed prospectively, all were culture negative, but 2 (3%) of the 64 bronchoalveolar lavage samples were positive for Legionella species by PCR. All 64 bronchoalveolar lavage samples were negative for the L. pneumophila assay. One of the two positive specimens was found to contain L. bozemanii and the other L. anisa. The L. bozemanii bronchoalveolar lavage sample was from a patient who had other culture-positive samples for L. bozemanii. Two (3%) of the 64 samples were found to contain inhibitory compounds. Two of the 10 throat swabs were positive for L. pneumophila, and all were culture negative; all 10 were negative in a Legionella spp. assay. Acute and convalescent serology samples from these patients demonstrated the presence of recent Legionella infection. A summary of the results obtained with clinical samples is shown in Table 3.
|
|
|---|
In the multiplex reaction, an internal control reaction has been included to check the validity of the PCR result by monitoring the nucleic acid extraction as well as presence of inhibitors. Of the 64 samples tested, 2 were shown to inhibit the PCR. The samples that are likely to be used for clinical diagnosis include sputum, bronchoalveolar lavage, and lung tissue samples, all of which may have inhibitors to PCR. Others have performed the internal control step separately (21, 23) or in duplex with either one of the Legionella assays (26), but not in the same tube.
The sensitive detection of Legionella spp. at the genus level as well as the differentiation between L. pneumophila and non-L pneumophila species is important in the case of clinically suspected pneumonia. As Legionella infection does not present with a distinctive clinical syndrome, it cannot be reliably differentiated from pneumonia due to other respiratory pathogens on the basis of signs and symptoms (19). The differentiation between L. pneumophila and Legionella species is also required by clinicians because L. pneumophila is associated with more significant morbidity and mortality. However, the importance of Legionella spp. other than L. pneumophila may be underrecognized, as routine diagnostics are more directed to L. pneumophila (18).
Several studies have found that PCR methods have a higher rate of detection than culture-based methods (9, 16), Although in this study the numbers are small, four more Legionella samples were identified by PCR. Two of the additional positives were for L. pneumophila, and those were both in throat swabs; no sputum sample was available in these cases. It is known that throat swabs are not as good a sample for culture, so this may explain why the culture was negative, as the serology was also positive. However, these results show that sputum production is not always possible in patients with Legionella infection and that PCR is a better alternative. In addition, the use of real-time PCR not only has good sensitivity but also decreases the turnaround time for results and shows a marked reduction in the risk of carryover contamination.
In order to perform this assay, additional controls to monitor for environmental contamination with Legionella spp. is also very important. Diagnostic results obtained should relate to Legionella in the clinical sample only. Use of kit-form DNA isolation systems does not diminish the problem of reagent-derived Legionella contamination (25). In addition, Taq polymerase has also been shown to be contaminated with bacterial DNA (4), and hence Legionella contamination is also possible in PCR master mixes.
The characteristics of this Legionella multiplex real-time PCR assay make it a useful addition for Legionella diagnosis. The assay is performed in a single tube with no post-PCR analysis required, and discrimination between L. pneumophila and other Legionella species is obtained in a single reaction.
PhHV was provided by Hubert Niesters, Erasmus Medical Center, Rotterdam, The Netherlands. The Legionella proficiency panel was provided by Marc Struelens, Erasmus Hospital, Brussels, Belgium.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»